panic disorder
AbbVie to buy drug developer Cerevel for $8.7 billion
Barbara Terrio
(Reuters) – AbbVie said on Wednesday it would buy Cerevel Therapeutics, a developer of drugs for neurological conditions, for about ...
(Reuters) – AbbVie said on Wednesday it would buy Cerevel Therapeutics, a developer of drugs for neurological conditions, for about ...